All Podcasts – Lifestyle
Author:
Clene Inc.
Clene Announces $7 Million Underwritten Offering of Common Stock
May 5, 2026
Clene to Present at Upcoming May Conferences
May 5, 2026
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
May 4, 2026
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
March 12, 2026